FDA Approves Airsupra Asthma Rescue Inhaler
AstraZeneca's Airsupra is the first FDA-approved combination of an inhaled corticosteroid and a short-acting beta-agonist for prevention of asthma exacerbations.
Tag: Astrazeneca
All
Latest
All
Latest
FDA OKs Tezspire for Severe Asthma
The FDA approved AstraZeneca and Amgen's medication, Tezspire, to treat severe asthma for patients aged 12 years and older.
All
Latest
Safety Board Expresses ‘Concern’ Over AstraZeneca Vaccine Data
A Data & Safety Monitoring Board expressed concern that AstraZeneca may have included outdated information in a Phase 3 trial for its COVID-19 vaccine.
FDA Approves Triple Therapy Breztri Aerosphere for COPD
Breztri Aerosphere is a single-inhaler, fixed dose triple-combination of the ICS budesonide, the LAMA glycopyrrolate, and LABA formoterol fumarate.
Read More
Early Positive Results in Study of Oxford’s COVID-19 Vaccine
The COVID-19 vaccine being developed by Oxford University and AstraZeneca led to an immune response in roughly 1,000 patients, early study results show.
Read More
Imfinzi Trial Shows Drug Can Boost Survival Rates in LUNG Cancer Patients
Data from a late-stage trial on the cancer drug Imfinzi, in combination with chemotherapies, demonstrated improvement in survival of certain lung cancer patients, AstraZeneca Plc announced this week.
Read More
Asthma Therapy Symbicort Improved Lung Function
New data demonstrated that the maintenance combination asthma therapy, Symbicort (budesonide/formoterol fumarate dehydrate), provides a rapid, clinically significant bronchodilatory response.
Read More